PATEL PURAV purchased 7.4% of their position (3K shares) of REVIVA PHARMACEUTICALS HOLDINGS, INC. on the open market
Open‑market purchase worth $14.1K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/21/2022ACC: 0001437749-22-027849
Director
Since Dec 2020
+3K
Net shares
Net buyer
$14.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
3K acquired
Non-Derivative Transactions1
Common Stock, par value $0.0001 per share
Direct
Shares
+3K
Price / share
$4.69
Trade value
$14.07K
% of position
7.4%
11/18/2022
40.55K→43.55K
Total
Net shares
+3K
Net value
$14.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Direct | 11/18/2022 | P · Purchase | +3K | $4.69 | $14.07K | 7.4% | 40.55K | 43.55K |
| Total | +3K | $14.07K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock, par value $0.0001 per share
IndirectShares owned3.32K
Common Stock, par value $0.0001 per share
IndirectShares owned28.74K
Total
32.06K indirect32.06K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.0001 per share | 3.32K | Indirect |
| Common Stock, par value $0.0001 per share | 28.74K | Indirect |
| Total | 32.06K | 32.06K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported